Imhoff John E sold GTHP
March 6, 2025 · Form 4 insider transaction
Imhoff John E sold 2,400.75 shares of Guided Therapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
Direction
Disposed (sell-side)
Shares
2,400.75
Price
N/A
Total value
N/A
InsiderImhoff John E
RoleDirector, 10% owner
SecurityPreferred Series C2 Stock
Transaction codeJ: J
Transaction dateMarch 6, 2025
Filing dateApril 17, 2025
Shares owned after0
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 6, 2025, Mr. Imhoff signed an exchange agreement to convert shares of Series C2 preferred stock at $0.50 conversion prices. For 2,400.75 Series C2 preferred shares, Mr. Imhoff received 4,801,500 common shares.